Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Colorectal Neoplasms

Free Subscription 22.12.2025 1 Ann Surg Oncol 1 BMC Cancer 1 BMC Gastroenterol 1 Cancer Lett 3 Clin Cancer Res 1 Clin Res Hepatol Gastroenterol 2 Dis Colon Rectum 1 Eur J Surg Oncol 3 Gastrointest Endosc 1 Gut 2 Int J Cancer 1 Int J Colorectal Dis 1 J Clin Oncol 2 Oncogene 4 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. AL MAHRIZI AD, Mossolem F, Major E, Elshafei O, et al
   Prophylactic Intraperitoneal Chemotherapy with Platinum Agents Following Curative Resection for Colorectal Cancer: A Systematic Review and Meta-Analysis.
   Ann Surg Oncol. 2025 Dec 16. doi: 10.1245/s10434-025-18903.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. YI Y, Cao Y, Guo Y, Cui Y, et al
   Serum untargeted metabolomics analysis of colorectal cancer.
   BMC Cancer. 2025 Dec 15. doi: 10.1186/s12885-025-15433.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

3. BRAUNER KB, Mashkoor M, Vogelsang RP, Bojesen RD, et al
   Days alive and out of hospital at 90 days as a composite outcome measure in patients undergoing elective surgery for colorectal cancer- a nationwide, observational study.
   BMC Gastroenterol. 2025 Dec 17. doi: 10.1186/s12876-025-04450.
   PubMed         Abstract available
   
   

   
   Cancer Lett

4. LOU S, Wang H, Mo G, Li H, et al
   A TRIM21-UCHL3-ITCH-SIPA1 axis promotes colorectal cancer growth and metastasis.
   Cancer Lett. 2025 Dec 16:218221. doi: 10.1016/j.canlet.2025.218221.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

5. CHRISTENSON ES, Ho WJ, Shu D, Durham JN, et al
   Correction: Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.
   Clin Cancer Res. 2025;31:5317.
   PubMed        
   
   
6. BENT AH, Dasari A, Smith JJ
   Are We There Yet? The Telltale Trail of ctDNA in Rectal Cancer.
   Clin Cancer Res. 2025;31:5117-5119.
   PubMed         Abstract available
   
   
7. AKIYOSHI T, Shinozaki E, Maeda Y, Taguchi S, et al
   ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial.
   Clin Cancer Res. 2025;31:5188-5197.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

8. GANDINI A, Probst V, Landi M, De Grandis MC, et al
   Switch from cetuximab to panitumumab during encorafenib-based therapy in BRAF V600E mutated metastatic colorectal cancer: an international multicenter analysis from the AGEO group.
   Clin Res Hepatol Gastroenterol. 2025 Dec 16:102746.
   PubMed         Abstract available
   
   

   
   Dis Colon Rectum

9. LI Z, Wu Y, Niu W
   Methodological Reflections on the Development of Breath VOC Models in Colorectal Cancer Screening.
   Dis Colon Rectum. 2025 Dec 19. doi: 10.1097/DCR.0000000000004098.
   PubMed        
   
   
10. BAEK SJ, Lim H, Kim Y
    Response to the Letter to the Editor: Methodological Reflections on the Development of Breath VOC Models in Colorectal Cancer Screening.
    Dis Colon Rectum. 2025 Dec 19. doi: 10.1097/DCR.0000000000004099.
    PubMed        
    
    

    
    Eur J Surg Oncol

11. EMILE SH, Horesh N, Wignakumar A, Boutros M, et al
    Advanced T stage and nodal disease are independently associated with worse cancer-specific survival in stage IV colorectal cancer: A SEER-based survival analysis.
    Eur J Surg Oncol. 2025;52:111315.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

12. GARG A
    Depth and dilemma: endoscopic submucosal dissection's efficacy in deep versus superficial colorectal cancer.
    Gastrointest Endosc. 2026;103:156-158.
    PubMed        
    
    
13. GUARDIOLA JJ, Lahr RE, Shultz J, Beran A, et al
    Success and safety of conventional endoscopic resection techniques for previously partially resected colorectal polyps at a tertiary referral center.
    Gastrointest Endosc. 2026;103:138-146.
    PubMed         Abstract available
    
    
14. VAN EIJCK VAN HESLINGA RAH, Didden P, Koch AD, Boonstra JJ, et al
    Short-term outcomes of endoscopic submucosal dissection for suspected T1 colorectal cancers: a European experience.
    Gastrointest Endosc. 2026;103:147-155.
    PubMed         Abstract available
    
    

    
    Gut

15. OSSWALD A, Wortmann E, Wylensek D, Kuhls S, et al
    Secondary bile acid production by gut bacteria promotes Western diet-associated colorectal cancer.
    Gut. 2025 Dec 18:gutjnl-2024-332243. doi: 10.1136/gutjnl-2024-332243.
    PubMed         Abstract available
    
    

    
    Int J Cancer

16. LUNENBERG RA, Franken IA, van der Baan FH, Sijtsma FPC, et al
    A comparison by mismatch repair status of real-world characteristics and outcomes in patients with stage II/III rectal cancer in the Netherlands.
    Int J Cancer. 2026;158:963-976.
    PubMed         Abstract available
    
    
17. LAN YQ, Hua MW, Peng S, Wang XL, et al
    Total neoadjuvant therapy with six versus four cycles of CAPOX in locally advanced rectal cancer: A real-world study.
    Int J Cancer. 2026;158:1031-1041.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

18. ADACHI T, Inoue Y, Okada S, Miyoshi T, et al
    Risk factors for bacterial translocation after loop ileostomy closure in patients with colorectal cancer.
    Int J Colorectal Dis. 2025;40:248.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

19. YEH JM, Seguin CL, Stratton KL, Leisenring WM, et al
    Benefits, Harms, and Burden of Colorectal Cancer Screening Among Childhood Cancer Survivors Previously Treated With Abdominopelvic Radiation.
    J Clin Oncol. 2025 Dec 17:JCO2500661. doi: 10.1200/JCO-25-00661.
    PubMed         Abstract available
    
    

    
    Oncogene

20. HUANG M, Xie W, Wu M, Ou Z, et al
    KRT81 promotes metastasis of colorectal cancer by acting as a protein scaffold for ezrin.
    Oncogene. 2025 Dec 17. doi: 10.1038/s41388-025-03665.
    PubMed         Abstract available
    
    
21. SU J, Zhao M, Feng W, Lin Y, et al
    TAF1 acetyltransferase promotes colorectal carcinoma metastasis by catalyzing beta-hydroxybutyrylation of KCTD9.
    Oncogene. 2026;45:87-103.
    PubMed         Abstract available
    
    

    
    PLoS One

22. ZHOU H, Fang L
    Integrated transcriptomic analysis reveals a CEBPB-DUSP1 axis driving tumor progression in colorectal cancer.
    PLoS One. 2025;20:e0337892.
    PubMed         Abstract available
    
    
23. HU J, Chen Z, Ma C, Fang Y, et al
    Analyses of the roles and potential targets of m7G-related genes in colorectal cancer using single-cell and bulk RNA sequencing data.
    PLoS One. 2025;20:e0337288.
    PubMed         Abstract available
    
    
24. 
    Correction: Additional outreach effort of providing an opportunity to obtain a kit for fecal immunochemical test during the general health check-up to improve colorectal cancer screening rate in Japan: A longitudinal study.
    PLoS One. 2025;20:e0339049.
    PubMed         Abstract available
    
    
25. FAN G, Zhang K, Yang X, Ding J, et al
    Correction: Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.
    PLoS One. 2025;20:e0338537.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

26. WANG Y, Huang ZJ, Yu NN, Liang JZ, et al
    MLKL/retromer axis controls PD-L1 recycling to compromise antitumor immunity during VCP inhibition-induced necroptosis.
    Proc Natl Acad Sci U S A. 2025;122:e2518675122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.